Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.

Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM.

Cancer Immunol Immunother. 2016 Jan 29. [Epub ahead of print]

PMID:
26825102
2.

Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial.

Miskulin DC, Majchrzak K, Tighiouart H, Muther RS, Kapoian T, Johnson DS, Weiner DE.

J Am Soc Nephrol. 2015 Dec 17. pii: ASN.2015040468. [Epub ahead of print]

PMID:
26677862
3.

Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.

Rybicka A, Mucha J, Majchrzak K, Taciak B, Hellmen E, Motyl T, Krol M.

J Physiol Pharmacol. 2015 Feb;66(1):29-37.

4.

Anaplastic transformation of low-grade gliomas (WHO II) on magnetic resonance imaging.

Bobek-Billewicz B, Stasik-Pres G, Hebda A, Majchrzak K, Kaspera W, Jurkowski M.

Folia Neuropathol. 2014;52(2):128-40.

PMID:
25118898
5.

MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling.

Mucha J, Majchrzak K, Taciak B, Hellmén E, Król M.

PLoS One. 2014 Jul 30;9(7):e103249. doi: 10.1371/journal.pone.0103249. eCollection 2014.

6.

MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.

Dobrakowski PP, Machowska-Majchrzak AK, Labuz-Roszak B, Majchrzak KG, Kluczewska E, Pierzchała KB.

Interv Neuroradiol. 2014 May-Jun;20(3):275-82. doi: 10.15274/NRJ-2014-10033. Epub 2014 Jun 17. Review.

7.

Canine mammary carcinoma cell line are resistant to chemosensitizers: verapamil and cyclosporin A.

Król M, Pawłowski KM, Majchrzak K, Mucha J, Motyl T.

Pol J Vet Sci. 2014;17(1):9-17.

PMID:
24724465
8.

Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.

Sztiller-Sikorska M, Koprowska K, Majchrzak K, Hartman M, Czyz M.

PLoS One. 2014 Mar 3;9(3):e90783. doi: 10.1371/journal.pone.0090783. eCollection 2014.

9.

Macrophages mediate a switch between canonical and non-canonical Wnt pathways in canine mammary tumors.

Król M, Mucha J, Majchrzak K, Homa A, Bulkowska M, Majewska A, Gajewska M, Pietrzak M, Perszko M, Romanowska K, Pawłowski K, Manuali E, Hellmen E, Motyl T.

PLoS One. 2014 Jan 3;9(1):e83995. doi: 10.1371/journal.pone.0083995. eCollection 2014.

10.

Assessment of explicit and implicit linguistic impairments in patients with aphasia after resection of tumour of the left cerebral hemisphere. Preliminary results.

Stomal-Słowińska MT, Daniluk B, Trela J, Słowiński J, Majchrzak K, Kądzielawa D, Majchrzak H.

Neurol Neurochir Pol. 2013 Nov-Dec;47(6):555-63.

PMID:
24375001
11.

The use of functional magnetic resonance imaging in reducing a risk of postoperative neurological deficits in the patients with brain tumour.

Tymowski M, Majchrzak K, Bobek-Billewicz B, Ladziński P, Majchrzak H.

Neurol Neurochir Pol. 2013 Nov-Dec;47(6):547-54.

PMID:
24375000
12.

Migrastatin analogues inhibit canine mammary cancer cell migration and invasion.

Majchrzak K, Lo Re D, Gajewska M, Bulkowska M, Homa A, Pawłowski K, Motyl T, Murphy PV, Król M.

PLoS One. 2013 Oct 8;8(10):e76789. doi: 10.1371/journal.pone.0076789. eCollection 2013.

13.

[Posterior petrosal approach - analysis of the surgical technique in cadavers simulation].

Ladziński P, Maliszewski M, Kaspera W, Majchrzak K, Tymowski M, Błaszczyk B.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):375-86. Review. Polish.

PMID:
23986428
14.

[Anterior petrosal approach - analysis of the surgical technique in cadavers simulation].

Ladziński P, Maliszewski M, Kaspera W, Majchrzak K, Tymowski M, Błaszczyk B.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):363-74. Review. Polish.

PMID:
23986427
15.

Meningiomas of the upper and middle part of the clivus and surrounding structures: early and long-term outcome.

Ladziński P, Majchrzak H, Kaspera W, Maliszewski M, Majchrzak K, Tymowski M, Adamczyk P, Błaszczyk B, Slaska-Kaspera A.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):332-44.

PMID:
23986423
16.

Markers of angiogenesis (CD31, CD34, rCBV) and their prognostic value in low-grade gliomas.

Majchrzak K, Kaspera W, Szymaś J, Bobek-Billewicz B, Hebda A, Majchrzak H.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):325-31.

PMID:
23986422
17.

Five markers useful for the distinction of canine mammary malignancy.

Pawłowski KM, Maciejewski H, Majchrzak K, Dolka I, Mol JA, Motyl T, Król M.

BMC Vet Res. 2013 Jul 11;9:138. doi: 10.1186/1746-6148-9-138.

18.

Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.

Pawłowski KM, Mucha J, Majchrzak K, Motyl T, Król M.

BMC Vet Res. 2013 Jun 17;9:119. doi: 10.1186/1746-6148-9-119.

19.

Reoperations of patients with low-grade gliomas in eloquent or near eloquent brain areas.

Kaspera W, Majchrzak K, Bobek-Billewicz B, Hebda A, Stasik-Pres G, Majchrzak H, Ladziński P, Machowska-Majchrzak A.

Neurol Neurochir Pol. 2013 Mar-Apr;47(2):116-25.

PMID:
23649999
20.

CSF-1R as an inhibitor of apoptosis and promoter of proliferation, migration and invasion of canine mammary cancer cells.

Król M, Majchrzak K, Mucha J, Homa A, Bulkowska M, Jakubowska A, Karwicka M, Pawłowski KM, Motyl T.

BMC Vet Res. 2013 Apr 5;9:65. doi: 10.1186/1746-6148-9-65.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk